Utility of 18F-FDG PET/CT for differential diagnosis between IgG4-related lymphadenopathy and angioimmunoblastic T-cell lymphoma
- 5 January 2024
- journal article
- research article
- Published by Elsevier in Clinical Radiology
- Vol. 79 (3) , 205-212
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Correlation Between SUVmax and CT Radiomic Analysis Using Lymph Node Density in PET/CT-Based Lymph Node StagingJournal of Nuclear Medicine, 2016
- Influence of Statistical Fluctuation on Reproducibility and Accuracy of SUVmax and SUVpeak: A Phantom StudyJournal of Nuclear Medicine Technology, 2015
- Abundance of IgG4+ Plasma Cells in Isolated Reactive Lymphadenopathy Is No Indication of IgG4-Related DiseaseAmerican Journal of Clinical Pathology, 2014
- Characterizing IgG4-related disease with 18F-FDG PET/CT: a prospective cohort studyEuropean Journal of Nuclear Medicine and Molecular Imaging, 2014
- Usefulness of 2‐[18F]‐fluoro‐2‐deoxy‐d‐glucose–Positron Emission Tomography/Computed Tomography for Staging and Evaluation of Treatment Response in IgG4‐Related Disease: A Retrospective Multicenter StudyArthritis Care & Research, 2013
- 18F-fluorodeoxyglucose positron emission tomography in the staging and prognosis of T cell lymphomaLeukemia & Lymphoma, 2013
- Lymphadenopathy of IgG4-related disease: an underdiagnosed and overdiagnosed entitySeminars in Diagnostic Pathology, 2012
- Utility of FDG PET/CT in IgG4-related systemic diseaseClinical Radiology, 2012
- FDG-PET in prediction of splenectomy findings in patients with known or suspected lymphomaLeukemia & Lymphoma, 2008
- Angioimmunoblastic T-Cell LymphomaMedicine, 2007